SEARCH   
MEMBER LOGIN      
Forgot Password?

Pharmaceutical Product Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pharmaceutical Product Manufacturing Market Research Report | ANZSIC C1841 | Nov 2016

Road to recovery: Modest revenue growth is expected due to ongoing reforms

The Pharmaceutical Product Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Industry Statistics & Market Size
Revenue
$10bn
Annual Growth 12-17
0.5%
Annual Growth 17-22
Add to Cart
Profit
Add to Cart
Employment
14,000
Businesses
331
Industry Analysis & Industry Trends

The Australian Pharmaceutical Product Manufacturing industry has contended with several challenges over the past five years. Echoing trends on the global pharmaceutical stage, these challenges have included a changing regulatory and risk environment, a patent cliff that has seen manufacturers lose exclusive manufacturing rights to some of the most profitable drugs in the industry's history, and reform-driven pricing pressures. On the local front, ongoing reforms to the Pharmaceutical Benefits Scheme (PBS) have been particularly significant, as mandatory price disclosures have continued to reduce prices. Increased regulatory burden and heightened competitive pressures have added to the challenges that local industry players are currently facing... purchase to read more

Industry Report - Starting a New Business Chapter

Substantial barriers to entry to the industry exist, not least of which is the fact that the industry is becoming increasingly globalised, with the dominant major players operating on a large global scale. The high and rising costs of R&D, combined with declining R&D productivity pose another substantial obstacle. A new medicine can cost as much as US$2.6 billion to develop with a 10 to 15 year time frame before it makes it to market. Furthermore according to Medicines Australia, it can then take 22 months to get a new medicine listed on the PBS. High capital expenditure is also required at the onset to establish a manufacturing plant geared to producing high-cost, high-technology drugs.

Government policies can be significant barriers to entry... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Pharmaceutical Product Manufacturing Industry?

The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Industry activities include manufacturing active pharmaceutical ingredients and synthesising chemical ingredients, late-stage packaging and fill-finish activities.

Industry Products
Benefit-paid pharmaceuticalsAll other medicationsVitamins and dietary supplementsOTC medicinesOther complementary medicines
 
Industry Activities
Antibacterial, antibiotic and antitoxinVaccineVitamin productHerbal drugAmpoule, medicinal capsule, medicinal ointment and vialBiotechnological pharmaceutical and medicinal productsSerum and blood serumDiagnostic substance


View Sample
Quote
Select Clients